Skip to main content
. 2011 Apr 28;2011:372509. doi: 10.1155/2011/372509

Table 1.

Clinical applications of PET with amino acid tracers in adult low-grade gliomas (LGGs).

Study Study design Tumor subtype1 no. of patients Results and/or conclusion
Differential diagnosis tumor versus nontumor lesions

Herholz et al. [60] Retrospective review Consecutive suspected tumors Measures: MET ratio, histology 196 patients (99 gliomas grade II) MET ratio 67% sensitivity and 72% specificity for differential diagnosis grade II gliomas versus nontumor lesions
Galldiks et al. [61] Consecutive series of children and young adults (2–21 year) with suspected tumors Measures: MET ratio, histology 39 patients (6 AI, 6 AII, 4 AIII, 2 OAIII) MET ratio 83% sensitivity & 92% specificity for differential diagnosis tumor versus nontumor lesions
Pichler et al. [62] Retrospective review Consecutive tumors or other intracerebral lesions Measures: FET ratio, MRI, histology 88 patients (19 gliomas grade I and grade II) FET ratio 94% sensitivity in HGG; 68% sensitivity in LGGs; 2 false positive cases (postischemic lesions) out of 10 nonbiopsy verified inflammatory lesions

Guiding stereotactic procedures and radiotherapy planning

Goldman et al. [37] Retrospective review Measures: MET ratio, FDG ratio, stereotactic guided histology 14 gliomas (93 biopsies) MET ratio correlates with anaplasia; FDG ratio correlates with anaplasia; inverse correlation MET ratio and necrosis; no correlation FDG ratio and necrosis
Levivier et al. [30] Retrospective review PET-guided radiosurgery Measures: MET volume, MRI 5 LGGs Spatial accuracy increased by MET volume, especially in ill-defined lesions on MRI
Nuutinen et al. [63] Prospective long-term followup Measures: MET ratio, MET volume, MRI, survival 14 gliomas (13 AII and 1 AIII) MET ratio and volume: 80% sensitivity in detecting postoperative residual tumor; benefit for radiotherapy planning in 3/14 patients with inconclusive MRI
Pirotte et al. [64] Retrospective review PET-guided stereotactic biopsy Measures: MET ratio, MET volume, FDG ratio, FDG volume, histology 10 LGGs (6 AII, 2 OII, 1 giant cell astrocytoma, 1 ganglioglioma) MET ratio corresponded to histology in 9 LGGs; FDG ratio corresponded to histology in 1 LGGs; MET volume superior to FDG volume, especially for cortical tumors

Evaluation of response to radiotherapy

Roelcke et al. [65] Postoperative followup of irradiated (n = 13) and nonirradiated (n = 17) patients Measures: MET ratio, FDG ratio 30 AII No differences in changes of MET and FDG ratio over time between two groups
Voges et al. [66] Followup of 125I brachytherapy Measures: FDG ratio and volume, MET ratio, and volume 39 gliomas (17 AII, 2 OII, 5 OAII, 1 AI, 2 unspecified, 3 grade III, 8 GB) Minimal effect of brachytherapy on FGD ratio1 year after seed implantation, but decline of MET ratio
Würker et al. [67] Follow up of 125I brachytherapy Measures: FDG ratio, MET ratio 10 LGGs (2 AI, 5 AII, 2  OAII, 1 OII) Significant decline in mean MET ratio before and 1 year after brachytherapy; no changes in mean FDG ratio; highest decline rates in tumors with high basal MET ratio

1Abbreviations: LGGs: low-grade gliomas; AI: pilocytic astrocytoma; AII: astrocytoma grade II; OII: oligodendroglioma grade II; OAII: oligoastrocytoma grade II; AIII: astrocytoma grade III; OAIII: oligoastrocytoma grade III; GB: glioblastoma.